Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.04 AUD
12.97 M AUD
171.56 M AUD
238.76 M
About NANOSONICS LIMITED
Sector
Industry
CEO
Michael Kavanagh
Website
Headquarters
Sydney
Founded
2000
ISIN
AU000000NAN9
FIGI
BBG000R7L8X7
Nanosonics Ltd. engages in the provision of research, development, and commercialization of infection control and decontamination products and related technologies. It operates through the following geographical segments: North America, Europe and Middle East, and Asia Pacific. Its products include trophon EPR, trophon technology, and trophon2. The company was founded by Maurie Stang on November 14, 2000 and is headquartered in Sydney, Australia.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of NAN is 2.96 AUD — it hasn't changed in the past 24 hours. Watch NANOSONICS LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange NANOSONICS LIMITED stocks are traded under the ticker NAN.
NAN stock has fallen by −0.67% compared to the previous week, the month change is a −13.70% fall, over the last year NANOSONICS LIMITED has showed a −33.93% decrease.
NAN stock is 1.02% volatile and has beta coefficient of 0.45. Track NANOSONICS LIMITED stock price on the chart and check out the list of the most volatile stocks — is NANOSONICS LIMITED there?
Today NANOSONICS LIMITED has the market capitalization of 898.50 M, it has decreased by −0.99% over the last week.
Yes, you can track NANOSONICS LIMITED financials in yearly and quarterly reports right on TradingView.
NANOSONICS LIMITED is going to release the next earnings report on Feb 25, 2025. Keep track of upcoming events with our Earnings Calendar.
NAN earnings for the last half-year are 0.02 AUD per share, whereas the estimation was 0.02 AUD, resulting in a 26.93% surprise. The estimated earnings for the next half-year are 0.02 AUD per share. See more details about NANOSONICS LIMITED earnings.
NANOSONICS LIMITED revenue for the last half-year amounts to 90.40 M AUD, despite the estimated figure of 90.57 M AUD. In the next half-year revenue is expected to reach 90.10 M AUD.
NAN net income for the last half-year is 6.80 M AUD, while the previous report showed 6.17 M AUD of net income which accounts for 10.31% change. Track more NANOSONICS LIMITED financial stats to get the full picture.
No, NAN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 21, 2024, the company has 466.00 employees. See our rating of the largest employees — is NANOSONICS LIMITED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NANOSONICS LIMITED EBITDA is 16.02 M AUD, and current EBITDA margin is 9.34%. See more stats in NANOSONICS LIMITED financial statements.
Like other stocks, NAN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NANOSONICS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NANOSONICS LIMITED technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NANOSONICS LIMITED stock shows the sell signal. See more of NANOSONICS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.